Package 83720-501-08

{"route": ["ORAL"], "spl_id": "2df63a0c-75c2-8126-e063-6294a90af910", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0383720501164"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["996520"], "spl_set_id": ["d0d7d651-0e5b-445a-8549-03795383d56c"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Oncor Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "237 mL in 1 BOTTLE (83720-501-08)", "package_ndc": "83720-501-08", "marketing_start_date": "20250201"}, {"sample": false, "description": "473 mL in 1 BOTTLE (83720-501-16)", "package_ndc": "83720-501-16", "marketing_start_date": "20250201"}], "brand_name": "Guaifenesin and Dextromethorphan hydrobromide", "product_id": "83720-501_2df63a0c-75c2-8126-e063-6294a90af910", "dosage_form": "LIQUID", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "83720-501", "generic_name": "Guaifenesin and Dextromethorphan hydrobromide Syrup", "labeler_name": "Oncor Pharmaceuticals", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Dextromethorphan hydrobromide", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "10 mg/5mL"}, {"name": "GUAIFENESIN", "strength": "100 mg/5mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250201", "listing_expiration_date": "20261231"}